IT201700083055A1 - “uso della proteina inibitore 2 della dissociazione di rho gdp come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali” - Google Patents
“uso della proteina inibitore 2 della dissociazione di rho gdp come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali”Info
- Publication number
- IT201700083055A1 IT201700083055A1 IT102017000083055A IT201700083055A IT201700083055A1 IT 201700083055 A1 IT201700083055 A1 IT 201700083055A1 IT 102017000083055 A IT102017000083055 A IT 102017000083055A IT 201700083055 A IT201700083055 A IT 201700083055A IT 201700083055 A1 IT201700083055 A1 IT 201700083055A1
- Authority
- IT
- Italy
- Prior art keywords
- dissociazione
- diagnostic
- inflammatory diseases
- protein inhibitor
- prognostic marker
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 230000000968 intestinal effect Effects 0.000 title 1
- 239000003550 marker Substances 0.000 title 1
- 229940121649 protein inhibitor Drugs 0.000 title 1
- 239000012268 protein inhibitor Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/286—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/286—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
- G01N2001/2866—Grinding or homogeneising
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/067—Pancreatitis or colitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000083055A IT201700083055A1 (it) | 2017-07-20 | 2017-07-20 | “uso della proteina inibitore 2 della dissociazione di rho gdp come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali” |
| EP18750514.4A EP3655781A1 (en) | 2017-07-20 | 2018-07-18 | Use of the rho gdp dissociation inhibitor 2 protein as a diagnostic and prognostic marker of intestinal inflammatory diseases |
| US16/632,709 US20200141949A1 (en) | 2017-07-20 | 2018-07-18 | Use of the rho gdp dissociation inhibitor 2 protein as a diagnostic and prognostic marker of intestinal inflammatory diseases |
| PCT/IB2018/055326 WO2019016719A1 (en) | 2017-07-20 | 2018-07-18 | USE OF RHO GDP DISSOCIATION INHIBITORY PROTEIN 2 AS A DIAGNOSTIC AND PROGNOSTIC MARKER FOR INFLAMMATORY BOWEL DISEASES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000083055A IT201700083055A1 (it) | 2017-07-20 | 2017-07-20 | “uso della proteina inibitore 2 della dissociazione di rho gdp come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali” |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IT201700083055A1 true IT201700083055A1 (it) | 2019-01-20 |
Family
ID=60990955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT102017000083055A IT201700083055A1 (it) | 2017-07-20 | 2017-07-20 | “uso della proteina inibitore 2 della dissociazione di rho gdp come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali” |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20200141949A1 (it) |
| EP (1) | EP3655781A1 (it) |
| IT (1) | IT201700083055A1 (it) |
| WO (1) | WO2019016719A1 (it) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7217351B2 (ja) * | 2019-07-08 | 2023-02-02 | 富士フイルム株式会社 | 画像処理装置、内視鏡システム、及び画像処理装置の作動方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1865071A1 (en) * | 2006-06-09 | 2007-12-12 | Rheinische Friedrich-Wilhelms-Universität Bonn | Method for early diagnosis of proliferative diabetic retinopathy |
| WO2007140508A1 (en) * | 2006-06-09 | 2007-12-13 | Proteome Systems Limited | Diagnostic and prognostic marker of an acute pulmonary exacerbation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8642349B1 (en) | 2006-08-11 | 2014-02-04 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Artificial neural network proteomic tumor classification |
| EP2391891A1 (en) | 2009-01-27 | 2011-12-07 | Proteogenix, Inc. | Biomarkers for detection of neonatal sepsis in biological fluid |
| IT1406051B1 (it) | 2010-08-05 | 2014-02-06 | D M G Italia S R L | Uso di hmgb1 come marcatore biologico di infiammazione intestinale umana, metodo non invasivo per la sua rilevazione in campioni fecali e kit relativo. |
-
2017
- 2017-07-20 IT IT102017000083055A patent/IT201700083055A1/it unknown
-
2018
- 2018-07-18 US US16/632,709 patent/US20200141949A1/en not_active Abandoned
- 2018-07-18 WO PCT/IB2018/055326 patent/WO2019016719A1/en not_active Ceased
- 2018-07-18 EP EP18750514.4A patent/EP3655781A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1865071A1 (en) * | 2006-06-09 | 2007-12-12 | Rheinische Friedrich-Wilhelms-Universität Bonn | Method for early diagnosis of proliferative diabetic retinopathy |
| WO2007140508A1 (en) * | 2006-06-09 | 2007-12-13 | Proteome Systems Limited | Diagnostic and prognostic marker of an acute pulmonary exacerbation |
Non-Patent Citations (3)
| Title |
|---|
| ANNA SHKODA ET AL: "Differential Protein Expression Profile in the Intestinal Epithelium from Patients with Inflammatory Bowel Disease", JOURNAL OF PROTEOME RESEARCH., vol. 6, no. 3, 1 March 2007 (2007-03-01), US, pages 1114 - 1125, XP055466501, ISSN: 1535-3893, DOI: 10.1021/pr060433m * |
| JEAN-PIERRE SEGAIN ET AL: "Rho kinase blockade prevents inflammation via nuclear factor kappaB inhibition: Evidence in Crohn's disease and experimental colitis", vol. 124, no. 5, 1 May 2003 (2003-05-01), pages 1180 - 1187, XP002699002, ISSN: 0016-5085, Retrieved from the Internet <URL:http://www.sciencedirect.com/science/article/pii/S001650850300283X> DOI: 10.1016/S0016-5085(03)00283-X * |
| NOAH P. ZIMMERMAN ET AL: "Cyclic AMP dysregulates intestinal epithelial cell restitution through PKA and RhoA* :", INFLAMMATORY BOWEL DISEASES, vol. 18, no. 6, 1 June 2012 (2012-06-01), US, pages 1081 - 1091, XP055466516, ISSN: 1078-0998, DOI: 10.1002/ibd.21898 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3655781A1 (en) | 2020-05-27 |
| WO2019016719A1 (en) | 2019-01-24 |
| US20200141949A1 (en) | 2020-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3903817A4 (en) | NOVEL ANTI-CRR8 ANTIBODY | |
| IL286373A (en) | Protein tyrosine phosphatase inhibitor compounds and uses thereof | |
| EP3914733A4 (en) | DETECTION OF ENDOTRIAL CANCER | |
| EP3822289A4 (en) | ANTI-SIRP-ALPHA ANTIBODIES | |
| EP3860453A4 (en) | Measurement system | |
| HUE062404T2 (hu) | Protein tirozin foszfatáz inhibitorok | |
| EP3761851C0 (en) | TISSUE MEASURING SENSOR | |
| IL275650B (en) | Diffraction based overlay scatterometry | |
| MA52004A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase | |
| MA54052A (fr) | Formulation d'anticorps | |
| MA52152A (fr) | Anticorps | |
| EP3864385A4 (en) | SNAP-SHOT ELLIPSOMETER | |
| IL280664A (en) | 2-arylbenzimidazoles as ppargc1a activators for treating neurodegenerative diseases | |
| EP3959508C0 (fr) | Systeme de mesure par deflectometrie | |
| MA54139A (fr) | Formulation d'anticorps | |
| HUE056885T2 (hu) | CREB-kötõ fehérjék inhibitorai | |
| EP4073464A4 (en) | POSITIONING AND ODOMETRICS SYSTEM | |
| IL288230A (en) | Identification of recurrent mutated neopeptides | |
| PL4017342T3 (pl) | Identyfikowanie części ciała | |
| MA53648A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glucopyranosidase | |
| IL263106A (en) | Integrated measurement system | |
| MA54097A (fr) | Anticorps anti-fn14 humain | |
| EP3814324A4 (en) | Cathepsin c inhibitors | |
| EP3850534A4 (en) | RECONSTRUCTION OF FINGERPRINT SUB-IMAGES | |
| EP3751266A4 (en) | SAMPLE HOLDER |